Brief: Robigo And Leaps By Bayer Announce Series A Financing To Advance Engineered Biologicals
17/09/2026 14:11
BRIEF-Robigo And Leaps By Bayer Announce Series A Financing To Advance Engineered Biologicals Sept 17 (Reuters) - Bayer AG BAYGn.DE:
ROBIGO AND LEAPS BY BAYER ANNOUNCE SERIES A FINANCING TO ADVANCE ENGINEERED BIOLOGICALS THAT PROTECT YIELDS AND REDUCE COSTS
ROBIGO: FUNDING WITH PARTICIPATION FROM ILLUMINA VENTURES, SVG THRIVE, CONGRUENT VENTURES, AND ENDEAVOR8
Source text: ID:nBw2zq4cba
Further company coverage: [BAYGn.DE]
(Gdansk Newsroom)
((((gdansk.newsroom@thomsonreuters.com ; +48 587785269; ));;))
Recent news on Bayer AG
See all newsBrief: Bayer Says Finerenone Slowed Kidney Decline In CKD
Insight: How cheap Chinese antibiotics threaten Europe's last major penicillin plant
Deutsche Bank AG FF - Post Stabilisation Notice -Bayer EUR 30NC6 & 30NC9
Brief: Bayer To Present New Finerenone Data Across Chronic Kidney Disease With And Without Diabetes At Asn Kidney Week 2026
Brief: FDA Approves Once-Weekly Generic Hormone Therapy Patch For Women